Followers | 14 |
Posts | 1483 |
Boards Moderated | 1 |
Alias Born | 02/12/2017 |
Thursday, April 19, 2018 12:19:25 PM
I didn't hear the whole testimony, but it wasn't surprising that GW Pharma got a unanimous "yes" today from the Advisory Committee. My expectation was always that it was more than likely to get a no, and the materials presented earlier this week certainly reinforced that view. The reason i expected no was years of backward thinking . BUT ITS A GO
The FDA is due to hand a final ruling, which I do expect to be yes, by 6/27.
I think the downside scenario is essentially gone and am adjusting my risk/reward calculation modestly.
Handcrafted cannabis investments
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM